Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury

Moretti, R, Chhor, V, Bettati, D, Banino, E, De Lucia, S, Le Charpentier, T, Lebon, S, Schwendimann, L, Pansiot, J, Rasika, S, Degos, V, Titomanlio, L, Gressens, P and Fleiss, B 2016, 'Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury', Journal of Neuroscience Research, vol. 94, no. 12, pp. 1546-1560.

Document type: Journal Article
Collection: Journal Articles

Title Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury
Author(s) Moretti, R
Chhor, V
Bettati, D
Banino, E
De Lucia, S
Le Charpentier, T
Lebon, S
Schwendimann, L
Pansiot, J
Rasika, S
Degos, V
Titomanlio, L
Gressens, P
Fleiss, B
Year 2016
Journal name Journal of Neuroscience Research
Volume number 94
Issue number 12
Start page 1546
End page 1560
Total pages 15
Publisher John Wiley & Sons, Inc.
Abstract The cognitive and behavioral deficits caused by traumatic brain injury (TBI) to the immature brain are more severe and persistent than injuries to the adult brain. Understanding this developmental sensitivity is critical because children under 4 years of age of sustain TBI more frequently than any other age group. One of the first events after TBI is the infiltration and degranulation of mast cells (MCs) in the brain, releasing a range of immunomodulatory substances; inhibition of these cells is neuroprotective in other types of neonatal brain injury. This study investigates for the first time the role of MCs in mediating injury in a P7 mouse model of pediatric contusion-induced TBI. We show that various neural cell types express histamine receptors and that histamine exacerbates excitotoxic cell death in primary cultured neurons. Cromoglycate, an inhibitor of MC degranulation, altered the inflammatory phenotype of microglia activated by TBI, reversing several changes but accentuating others, when administered before TBI. However, without regard to the time of cromoglycate administration, inhibiting MC degranulation did not affect cell loss, as evaluated by ventricular dilatation or cleaved caspase-3 labeling, or the density of activated microglia, neurons, or myelin. In double-heterozygous cKit mutant mice lacking MCs, this overall lack of effect was confirmed. These results suggest that the role of MCs in this model of pediatric TBI is restricted to subtle effects and that they are unlikely to be viable neurotherapeutic targets. © 2016 Wiley Periodicals, Inc.
Subject Neurology and Neuromuscular Diseases
Keyword(s) apoptosis
DOI - identifier 10.1002/jnr.23911
Copyright notice © 2016 Wiley Periodicals, Inc.
ISSN 0360-4012
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 12 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 22 Abstract Views  -  Detailed Statistics
Created: Thu, 31 Jan 2019, 11:26:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us